تحميل...
Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of Small Cell Lung Cancer
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Chinês |
| منشور في: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-04-01
|
| سلاسل: | Chinese Journal of Lung Cancer |
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|